Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 N6-adenosine methylation (m6A): a promising new molecular target in hypertension and cardiovascular diseases.

Literature DB >> 31578458

N6-adenosine methylation (m6A): a promising new molecular target in hypertension and cardiovascular diseases.

Arumugam Paramasivam¹, Jayaseelan Vijayashree Priyadharsini², Subramanian Raghunandhakumar³.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2019 PMID： 31578458 DOI： 10.1038/s41440-019-0338-z

Source DB: PubMed Journal: Hypertens Res ISSN： 0916-9636 Impact factor: 3.872

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. A Computational Data Mining Strategy to Identify the Common Genetic Markers of Temporomandibular Joint Disorders and Osteoarthritis.

Authors: Vijayashree Priyadharsini Jayaseelan; Paramasivam Arumugam
Journal: Glob Med Genet Date: 2022-03-09

2. ZNF677 suppresses renal cell carcinoma progression through N6-methyladenosine and transcriptional repression of CDKN3.

Authors: Aolin Li; Congcong Cao; Ying Gan; Xiaofei Wang; Tianyu Wu; Quan Zhang; Yuchen Liu; Lin Yao; Qian Zhang
Journal: Clin Transl Med Date: 2022-06

3. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.

Authors: Xin Wang; Linli Tian; Yushan Li; Jingting Wang; Bingrui Yan; Like Yang; Qiuying Li; Rui Zhao; Ming Liu; Peng Wang; Yanan Sun
Journal: J Exp Clin Cancer Res Date: 2021-02-26

4. RNAWRE: a resource of writers, readers and erasers of RNA modifications.

Authors: Fulei Nie; Pengmian Feng; Xiaoming Song; Meng Wu; Qiang Tang; Wei Chen
Journal: Database (Oxford) Date: 2020-01-01 Impact factor: 3.451

5. Identification of m6A-related genes and m6A RNA methylation regulators in pancreatic cancer and their association with survival.

Authors: Yan Geng; Renguo Guan; Weifeng Hong; Bowen Huang; Peizhen Liu; Xiaohua Guo; Shixiong Hu; Min Yu; Baohua Hou
Journal: Ann Transl Med Date: 2020-03

6. The N6-Methyladenosine- (m6A-) Associated Genes Act as Strong Key Biomarkers for the Prognosis of Pancreatic Adenocarcinoma.

Authors: Fei Li; Ping Zhang
Journal: Comput Math Methods Med Date: 2021-11-19 Impact factor: 2.238

N6-adenosine methylation (m6A): a promising new molecular target in hypertension and cardiovascular diseases.

1. A Computational Data Mining Strategy to Identify the Common Genetic Markers of Temporomandibular Joint Disorders and Osteoarthritis.

2. ZNF677 suppresses renal cell carcinoma progression through N6-methyladenosine and transcriptional repression of CDKN3.

3. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.

4. RNAWRE: a resource of writers, readers and erasers of RNA modifications.

5. Identification of m6A-related genes and m6A RNA methylation regulators in pancreatic cancer and their association with survival.

6. The N6-Methyladenosine- (m6A-) Associated Genes Act as Strong Key Biomarkers for the Prognosis of Pancreatic Adenocarcinoma.

7. m6A methylation regulators as predictors for treatment of advanced urothelial carcinoma with anti-PDL1 agent.

Review 8. RNA N6-methyladenosine: a promising molecular target in metabolic diseases.

Review 9. Role of m6A RNA methylation in cardiovascular disease (Review).

Review 10. Novel methylation mark and essential hypertension.